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Allergic contact dermatitis induced by zinc pyrithione 
in shampoo: a case report
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ABSTRACT
Shampoo-induced allergic contact dermatitis is difficult to diagnose clinically because 
it can involve multiple and variable areas where the shampoo flows. Zinc pyrithione is a 
common active agent in medicated shampoo that is known to have good anti-dandruff 
and antifungal effects. Despite its low risk of sensitization, cases of allergic contact der-
matitis still occur because of the popularity of such products. We report a 33-year-old 
man who developed pruritic rash on his scalp, face, neck, and hands after using a new 
shampoo containing zinc pyrithione. A patch test revealed a positive reaction to zinc 
pyrithione and personal shampoo containing zinc pyrithione.
Copyright © 2010, Taiwanese Dermatological Association. 
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Introduction
Shampoo is the most commonly used hair product on the 
market. Although it is quickly rinsed away and it is not in 
contact with skin for a long period, shampoo-induced al-
lergic contact dermatitis is still the third leading cause of 
patients’ own product-related scalp dermatitis.1 Numerous 
ingredients are added to satisfy different kinds of hair char-
acteristics and customers’ demands.
Zinc pyrithione is a common active ingredient with a 
low potential of irritation and sensitization in antidandruff 
shampoo; it is often recommended for individuals with se-
borrheic dermatitis or psoriasis. Two mechanisms of anti-
dandruff effects have been studied: (1) zinc pyrithione is an 
antifungal agent that interferes with the primary proton 
pump in fungus membranes;2 and (2) zinc pyrithione has 
cytotoxic effects on rapidly proliferating epidermis cells.3,4 
Despite its frequent and widespread use, very few cases of 
zinc pyrithione-induced allergic contact dermatitis have been 
documented. We present a case of allergic contact derma-
titis due to a shampoo containing zinc pyrithione, which 
was further confirmed by a positive patch test result.
Case report
A 33-year-old male cement worker who had no history of 
atopic diseases or drug allergy presented to our emergency 
room because of itching edematous erythema and erythema-
tous papules over his scalp, forehead, eyelids, ears, nape, 
neck, wrists, and hands (Figure 1). This patient had been suf-
fering from increasing dandruff for years. Before the onset 
of the skin rash, he had begun using a new anti-dandruff 
shampoo (Anti-Dandruff Conditioning Shampoo, manufac-
tured by Procter & Gamble Co., Cincinnati, OH, USA) con-
taining 0.45% of zinc pyrithione. He denied use of hair dye 
recently. Under the impression of contact dermatitis to the 
new shampoo or cement dust that he was exposed to at 
work, a topical steroid and oral hydroxyzine were given 
and skin lesions gradually resolved.
One month after he began taking medication, a patch test 
was performed with European Standard Series, common 
shampoo allergens (Chemotechnique Diagnostics, Malmo, 
Sweden), and personal shampoo. Readings were carried out 
on days 2, 3 and 7, according to the International Contact 
Dermatitis Research Group recommendations. The patient 
had positive reactions to zinc pyrithione, the 2% and 5% 
dilution of his new shampoo containing zinc pyrithione 
(Figure 2 and Table 1). The results of the tests with diluted 
shampoo (2% and 5% aq.) were negative in five healthy 
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volunteer controls. A positive reaction to cocamidopropyl 
betaine of common shampoo allergens was also noted in 
the patient, but his shampoo did not contain cocamido-
propyl betaine. Allergic contact dermatitis to zinc pyrithione 
was diagnosed.
After the patient stopped using the shampoo containing 
zinc pyrithione, he had no recurrence of the dermatitis.
Discussion
The clinical diagnosis of shampoo-induced allergic contact 
dermatitis is difficult because of its multiple and variable 
distribution. It can present as either scalp dermatitis, eyelid 
dermatitis, facial dermatitis, neck dermatitis, dermatitis of 
the upper trunk, and even hand dermatitis, or a combi-
nation of these. In fact, the reaction can occur on any sur-
face that is exposed to the shampoo. Since many shampoos 
are quite similar in their ingredients, changing from one 
suspected shampoo to another may not relieve or improve 
the symptoms.
The identification of definite allergens in each case is also 
challenging. Most shampoos contain numerous ingredients, 
ranging from 4 to 30 ingredients in one shampoo alone.5 
Many ingredients are not included in routine patch test series. 
Patch tests with personal products may help to identify the 
causative allergens.1 Interpreting the results of patch tests 
also requires much care because of a high false-positive rate. 
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Figure 1 Edematous erythema, desquamation, and erythematous papules on the patient’s (A) forehead and eyelids, (B) ear and hairline, (C) nape, 
and (D) hands are shown.
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2% shampoo
5% shampoo
Figure 2 Positive patch test reactions to zinc pyrithione and to sham-
poo in 2% and 5% aqueous forms.
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Of all products applied on the scalp, irritant and question-
able patch test reactions occur most frequently in hair 
cleaning products because of their unusually long stay and 
occlusive conditions in patch tests.1 Selection of a proper 
diluted concentration and using a control group can improve 
the accuracy of patch tests.
The allergens most commonly present in shampoos are 
fragrance, cocamidopropyl betaine, methylchloroisothia-
zolinone/methylisothiazolinone, formaldehyde releasers, 
propylene glycol, vitamin E, parabens, benzophenones, iodo-
propynyl butylcarbamate, and methyldibromoglutaronitrile/
phenoxyethanol preservatives.5 Compared with the wide-
spread and frequent use of zinc pyrithione in anti-dandruff 
shampoos, allergic contact dermatitis to zinc pyrithione is 
extremely rare. The positive patch test rate of zinc pyrithione 
ranges from 0.2%6 to 1.2%.7
After reviewing the related English literature, we found 
nine additional reports (12 patients) of allergic contact der-
matitis caused by zinc pyrithione.6,8–15 In all patients, the zinc 
pyrithione-containing products were shampoos. Most cases 
presented with scalp dermatitis and often there was wide-
spread involvement of the face, neck, shoulders, upper trunk, 
and hands where the shampoo may come into contact. The 
skin lesions were generally eczematous. In two patients with 
psoriasis, it presented as acute exacerbated pustular psoriasis 
with Koebner’s phenomenon after contact dermatitis caused 
by zinc pyrithione.14,15 Yates and Finn10 reported one case of 
photosensitivity dermatitis and actinic reticuloid syndrome 
following contact dermatitis to zinc pyrithione. However, 
the causative relationship of photosensitivity is controver-
sial and this phenomenon was not noted in any of the other 
cases.
Calnan8 reported the cross-reactivity of zinc pyrithione, 
piperazine, hydroxyzine hydrochloride, and ethylenediamine 
hydrochloride. In our patient, hydroxyzine was prescribed 
to relieve symptoms. No aggravation or new skin lesions was 
found.
Our patient also had a positive patch test reaction to 
cocamidopropyl betaine, an amphoteric surfactant and a 
frequent sensitizer in shampoo.16 Irritant reaction to coca-
midopropyl betaine appears frequently in patch tests.17 Our 
case did not use any shampoo containing cocamidopropyl 
betaine before the skin rash occurred.
In conclusion, dermatologists should be aware of possi-
ble shampoo-induced allergic contact dermatitis, especially 
diffuse dermatitis involving the scalp, face, neck, upper trunk, 
and hands. Patch tests should be performed with available 
shampoo allergens and personal shampoos to screen for 
possible allergens. Careful exclusion of false-positive reac-
tions and testing with a control group may also help clarify 
allergens. Patients must be educated to read the ingredients 
of shampoos carefully and to avoid allergens. In patients 
allergic to zinc pyrithione, cross-reactivity with piperazine, 
hydroxyzine, and ethylenediamine hydrochloride may occur.
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